Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Friess

Showing results (681-690 of 770) with videos related to

Pageof 77
Sort By:
BJS Open|March 7, 2023
Applicability of the surgical risk calculator by the American College of Surgeons in the setting of German patients undergoing complete pancreatectomy: multicentre study using data from the StuDoQ|Pancreas registryPhilipp Höhn, Fabian Runde, Andreas Minh Luu, et al.
The American Journal of Surgical Pathology|June 9, 2021
Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 CasesMoritz Jesinghaus, Maxime Schmitt, Corinna Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Co-clinical Assessment of Tumor Cellularity in Pancreatic CancerIrina Heid, Katja Steiger, Marija Trajkovic-Arsic, et al.
The Journal of Supportive Oncology|February 9, 2008
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexiaBertram Wiedenmann, Peter Malfertheiner, Helmut Friess, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 28, 2020
Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammationPaulo L Pfitzinger, Laura Fangmann, Kun Wang, et al.
Gut|January 15, 2016
Activated Schwann cells in pancreatic cancer are linked to analgesia via suppression of spinal astroglia and microgliaIhsan Ekin Demir, Elke Tieftrunk, Stephan Schorn, et al.
Molecular Carcinogenesis|October 14, 2017
Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathwayBin Zhang, Chao Deng, Lei Wang, et al.
Proteomics. Clinical Applications|December 8, 2010
Towards a comprehensive proteome of normal and malignant human colon tissue by 2-D-LC-ESI-MS and 2-DE proteomics and identification of S100A12 as potential cancer biomarkerMichael Thierolf, Marie-Luise Hagmann, Michael Pfeffer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2014
Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignanciesGiovanni Marchegiani, Giuseppe Malleo, Jan G D'Haese, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 7, 2023
The other colon cancer: a population-based cohort study of appendix tumour trends and prognosisKathrin Halfter, Gabriele Schubert-Fritschle, Frederick Klauschen, et al.
Pageof 77

Showing results (681-690 of 770) with videos related to

Sort By:
Pageof 77
BJS Open|March 7, 2023
Applicability of the surgical risk calculator by the American College of Surgeons in the setting of German patients undergoing complete pancreatectomy: multicentre study using data from the StuDoQ|Pancreas registryPhilipp Höhn, Fabian Runde, Andreas Minh Luu, et al.
The American Journal of Surgical Pathology|June 9, 2021
Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 CasesMoritz Jesinghaus, Maxime Schmitt, Corinna Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Co-clinical Assessment of Tumor Cellularity in Pancreatic CancerIrina Heid, Katja Steiger, Marija Trajkovic-Arsic, et al.
The Journal of Supportive Oncology|February 9, 2008
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexiaBertram Wiedenmann, Peter Malfertheiner, Helmut Friess, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 28, 2020
Indirect cholinergic activation slows down pancreatic cancer growth and tumor-associated inflammationPaulo L Pfitzinger, Laura Fangmann, Kun Wang, et al.
Gut|January 15, 2016
Activated Schwann cells in pancreatic cancer are linked to analgesia via suppression of spinal astroglia and microgliaIhsan Ekin Demir, Elke Tieftrunk, Stephan Schorn, et al.
Molecular Carcinogenesis|October 14, 2017
Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathwayBin Zhang, Chao Deng, Lei Wang, et al.
Proteomics. Clinical Applications|December 8, 2010
Towards a comprehensive proteome of normal and malignant human colon tissue by 2-D-LC-ESI-MS and 2-DE proteomics and identification of S100A12 as potential cancer biomarkerMichael Thierolf, Marie-Luise Hagmann, Michael Pfeffer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2014
Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignanciesGiovanni Marchegiani, Giuseppe Malleo, Jan G D'Haese, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 7, 2023
The other colon cancer: a population-based cohort study of appendix tumour trends and prognosisKathrin Halfter, Gabriele Schubert-Fritschle, Frederick Klauschen, et al.
Pageof 77